Trial Profile

A Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AB-16B5 in Subjects With an Advanced Solid Malignancy

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sotevtamab (Primary)
Indications Solid tumours
Focus Adverse reactions; First in man
Sponsors Alethia BioTherapeutics

Most Recent Events

27 Jun 2017 Status changed from recruiting to completed.
05 Apr 2017 Results (n=15) assessing safety and tolerability, presented at the 108th Annual Meeting of the American Association for Cancer Research
14 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Oct 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com